Continuous quality improvement interventions to improve long-term outcomes of antiretroviral therapy in women who initiated therapy during pregnancy or breastfeeding in the Democratic Republic of Congo: design of an open-label, parallel, group randomized trial

Marcel Yotebieng, Frieda Behets, Bienvenu Kawende, Noro Lantoniaina Rosa Ravelomanana, Martine Tabala, Emile W Okitolonda, Marcel Yotebieng, Frieda Behets, Bienvenu Kawende, Noro Lantoniaina Rosa Ravelomanana, Martine Tabala, Emile W Okitolonda

Abstract

Background: Despite the rapid adoption of the World Health Organization's 2013 guidelines, children continue to be infected with HIV perinatally because of sub-optimal adherence to the continuum of HIV care in maternal and child health (MCH) clinics. To achieve the UNAIDS goal of eliminating mother-to-child HIV transmission, multiple, adaptive interventions need to be implemented to improve adherence to the HIV continuum.

Methods: The aim of this open label, parallel, group randomized trial is to evaluate the effectiveness of Continuous Quality Improvement (CQI) interventions implemented at facility and health district levels to improve retention in care and virological suppression through 24 months postpartum among pregnant and breastfeeding women receiving ART in MCH clinics in Kinshasa, Democratic Republic of Congo. Prior to randomization, the current monitoring and evaluation system will be strengthened to enable collection of high quality individual patient-level data necessary for timely indicators production and program outcomes monitoring to inform CQI interventions. Following randomization, in health districts randomized to CQI, quality improvement (QI) teams will be established at the district level and at MCH clinics level. For 18 months, QI teams will be brought together quarterly to identify key bottlenecks in the care delivery system using data from the monitoring system, develop an action plan to address those bottlenecks, and implement the action plan at the level of their district or clinics.

Discussion: If proven to be effective, CQI as designed here, could be scaled up rapidly in resource-scarce settings to accelerate progress towards the goal of an AIDS free generation.

Trial registration: The protocol was retrospectively registered on February 7, 2017. ClinicalTrials.gov Identifier: NCT03048669 .

Keywords: Cluster-randomized trial; Continuous quality improvement; DR Congo; Prevention of mother-to-child transmission; Universal test-and-treat.

References

    1. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2013. .
    1. UNAIDS. Prevention gap report, 2016.
    1. Sibanda E, Weller I, Hakim J, Cowan F. The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care: a systematic review and meta-analysis. AIDS. 2013;27(17):2787–97. doi:10.1097/QAD.0000000000000027.
    1. UNAIDS . 2014 progress report on the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. 2014.
    1. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. Geneva, Switzerland; 2013. p. 198.
    1. UNAIDS. Fact sheet November 2016, 2016.
    1. UNAIDS. Global plan towards the elimination of new HIV intections among children by 2015 and keeping their mothers alive 2011. . Accessed 21 Apr 2017.
    1. Cowing M, Davino-Ramaya CM, Ramaya K, Szmerekovsky J. Health Care Delivery Performance: Service, Outcomes, and Resource Stewardship. Perm J. 2009;13(4):72–78. doi: 10.7812/TPP/08-100.
    1. Improvement. IfH. The Breakthrough Series: IHI’s Collaborative Model for Achieving Breakthrough Improvement.2003. . Accessed 21 Apr 2017.
    1. Schouten LMT, Hulscher MEJL, Everdingen JJE, Huijsman R, Grol RPTM. Evidence for the impact of quality improvement collaboratives: systematic review. 2008.
    1. Landon BE, Wilson IB, McInnes K, et al. Effects of a quality improvement collaborative on the outcome of care of patients with HIV infection: the EQHIV study. Ann Intern Med. 2004;140(11):887–896. doi: 10.7326/0003-4819-140-11-200406010-00010.
    1. Bhardwaj S, Barron P, Pillay Y, et al. Elimination of mother-to-child transmission of HIV in South Africa: rapid scale-up using quality improvement. S. Afr. Med. J. 2014;104(3 Suppl 1):239–243. doi: 10.7196/SAMJ.7605.
    1. Barker P, Barron P, Bhardwaj S, Pillay Y. The role of quality improvement in achieving effective large-scale prevention of mother-to-child transmission of HIV in South Africa. AIDS (London, England) 2015;29:S137–S143. doi: 10.1097/QAD.0000000000000718.
    1. Youngleson MS, Nkurunziza P, Jennings K, Arendse J, Mate KS, Barker P. Improving a mother to child HIV transmission programme through health system redesign: quality improvement, protocol adjustment and resource addition. PLoS One. 2010;5(11):e13891. doi: 10.1371/journal.pone.0013891.
    1. Doherty T, Chopra M, Nsibande D, Mngoma D. Improving the coverage of the PMTCT programme through a participatory quality improvement intervention in South Africa. BMC Public Health. 2009;9:406. doi: 10.1186/1471-2458-9-406.
    1. Mate KS, Ngubane G, Barker PM. A quality improvement model for the rapid scale-up of a program to prevent mother-to-child HIV transmission in South Africa. International J. Qual. Health Care. 2013;25(4):373–380. doi: 10.1093/intqhc/mzt039.
    1. Internationa MdPeM . Enquête Démographique et de Santé, République Démocratique du Congo 2007. Calverton: Ministère du Plan et Macro International; 2008.
    1. International MdPeM . Démographique et de Santé, République Démocratique du Congo 2013-1014: Rapport Préliminaire sur la Prévalence du VIH. Calverton: Ministère du Plan et Macro International; 2014.
    1. Yotebieng M, van Rie A, Luisiama J, et al. Survival, clinical, immunological and hematological outcomes of antiretroviral therapy among HIV-infected children attending a public clinic in Kinshasa, Democratic Republic of Congo. Int J Infect Dis. 2010;14:e247. doi: 10.1016/j.ijid.2010.02.2037.
    1. Yotebieng M, Wenzi LK, Basaki E, Batumbula ML, Tabala M, Mungoyo E, Mangala R, Behets F. Provider-Initiated HIV testing and counseling among patients with presumptive tuberculosis in Democratic Republic of Congo. Pan Afr Med J. 2016;25:161.
    1. Yotebieng M, Tabala M, Batumbula ML, Wenzi L, Basaki E, Mungoyo E, Mangala R, Behets F. Impact of WHO 2010 Guidelines on Antiretroviral Therapy Initiation among Patients with HIV-Associated Tuberculosis in Clinics with and without Onsite HIV Services in the Democratic Republic of Congo. Tuberc Res Treat. 2016;2016:1027570.
    1. Mbonze NB, Tabala M, Wenzi LK, Bakoko B, Brouwer M, Creswell J, Van Rie A, Behets F, Yotebieng M. Xpert(®) MTB/RIF for smear-negative presumptive TB: impact on case notification in DR Congo. Int J Tuberc Lung Dis. 2016;20(2):240–6.
    1. Yotebieng M, Maskew M, Van Rie A. CD4+ gain percentile curves for monitoring response to antiretroviral therapy in HIV-infected adults. AIDS (London, England) 2015;29(9):1067–1075. doi: 10.1097/QAD.0000000000000649.
    1. Yotebieng M, Norris A, Chalachala JL, Matumona Y, Ramadhani HO, Behets F. Fertility desires, unmet need for family planning, and unwanted pregnancies among HIV-infected women in care in Kinshasa, DR Congo. Pan Afr Med J. 2015;20:235.
    1. Yotebieng M, Chalachala JL, Labbok M, Behets F. Infant feeding practices and determinants of poor breastfeeding behavior in Kinshasa, Democratic Republic of Congo: a descriptive study. Int Breastfeed J. 2013;8(1):11. doi: 10.1186/1746-4358-8-11.
    1. Van Rie A, Patel MR, Nana M, et al. Integration and task shifting for TB/HIV care and treatment in highly resource-scarce settings: one size may not fit all. J. Acquir. Immune Defic. Syndr. 2014;65(3):e110–e117. doi: 10.1097/01.qai.0000434954.65620.f3.
    1. Thompson D, Edmonds A, Lusiama J, et al. Field evaluation of a prevention of mother-to-child transmission program in the democratic republic of Congo using DNA PCR test results- implications for increased intervention impact. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Rome, Italy; 2011. p. Abstract # TUPE277.
    1. Patel MR, Yotebieng M, Behets F, Vanden Driessche K, Nana M, Van Rie A. Outcomes of integrated treatment for tuberculosis and HIV in children at the primary health care level. Int. J. Tuberc. Lung Dis. 2013;17(9):1206–1211. doi: 10.5588/ijtld.12.0833.
    1. Patel MR, Nana M, Yotebieng M, Tabala M, Behets F, Van Rie A. Delayed antiretroviral therapy despite integrated treatment for tuberculosis and HIV infection. Int. J. Tuberc. Lung Dis. 2014;18(6):694–699. doi: 10.5588/ijtld.13.0807.
    1. Moore K, Van Rie A, Bahati E, et al. Retention in Care in a TB/HIV Treatment Program. 42nd Union World Conference on Lung Health. Lille, France; 2011. p. Abstract # OP-771-28.
    1. Kitetele F, Yotebieng M, Luisiama J, et al. Effet de l’infection à VIH sur la mortalité des enfants rougeoleux en milieu hospitalier. 5eme Conference Francophone VIH/SIDA; 2010 March 28-31, 2010; Casablanca, Morocco; 2010. p. Abstract # 283/56P
    1. Edmonds A, Yotebieng M, Lusiama J, et al. Quantification of CD4 responses to combined antiretroviral therapy over 5 years among HIV-infected children in Kinshasa, Democratic Republic of Congo. J. Acquir. Immune Defic. Syndr. 2012;61(1):90–98. doi: 10.1097/QAI.0b013e31825bd9b7.
    1. Eldridge S, Cryer C, Feder G, Underwood M. Sample size calculations for intervention trials in primary care randomizing by primary care group: an empirical illustration from one proposed intervention trial. Stat Med. 2001;20(3):367–376. doi: 10.1002/1097-0258(20010215)20:3<367::AID-SIM798>;2-R.
    1. Donner A, Birkett N, Buck C. Randomization by cluster. Sample size requirements and analysis. Am J Epidemiol. 1981;114(6):906–914. doi: 10.1093/oxfordjournals.aje.a113261.
    1. Yotebieng M, Labbok M, Soeters HM, Chalachala JL, Lapika B, Vitta BS, Behets F. Ten Steps to Successful Breastfeeding programme to promote early initiation and exclusive breastfeeding in DR Congo: a cluster-randomised controlled trial. Lancet Glob Health. 2015;3(9):e546–55.
    1. Yotebieng M, Thirumurthy H, Moracco KE, et al. Conditional cash transfers and uptake of and retention in prevention of mother-to-child HIV transmission care: a randomised controlled trial. Lancet HIV. 2016;3(2):e85–e93. doi: 10.1016/S2352-3018(15)00247-7.
    1. Hozumi D, Fronczak N, Minichiello NS, et al. Profiles of Health Facility Assessment Methods: MEASURE Evaluation, 2006.
    1. Oyeledun B, Oronsaye F, Oyelade T, et al. Increasing retention in care of HIV-positive women in PMTCT services through continuous quality improvement-breakthrough (CQI-BTS) series in primary and secondary health care facilities in Nigeria: a cluster randomized controlled trial. The Lafiyan Jikin Mata Study. J Acquir Immune Defic Syndr. 2014;67(Suppl 2):S125–S131. doi: 10.1097/QAI.0000000000000320.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa